Trials / Unknown
UnknownNCT03549195
TMTP1 Targeting Micro-metastasis LN in Laparoscopic SLN Detection in Cervical Cancer
Novel Tumor Targeted Fluorescent Peptide TMTP1-ICG Mapping in Laparoscopic Sentinel Micro-metastasis Lymph Node Detection in Cervical Cancer Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Huazhong University of Science and Technology · Academic / Other
- Sex
- Female
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Investigators aimed to determine the validity of the investigator's novel tumor targeted fluorescent peptide TMTP1-ICG to increased accuracy of laparoscopic SLN mapping
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ICG | The ICG powder was diluted and injected into the cervix, divided into 3 and 9 o'clock position, 4 hours before surgery. |
| PROCEDURE | ICG-CP | The ICG-CP powder was diluted and injected into the cervix, divided into 3 and 9 o'clock position, 4 hours before surgery. |
| PROCEDURE | ICG-TMTP1 | The ICG-TMTP1 powder was diluted and injected into the cervix, divided into 3 and 9 o'clock position, 4 hours before surgery. |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2019-06-01
- Completion
- 2019-12-31
- First posted
- 2018-06-07
- Last updated
- 2018-06-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03549195. Inclusion in this directory is not an endorsement.